Novo Nordisk Stops Ozempic Kidney Trial After Early Success

Novo Nordisk will stop a trial studying Ozempic to treat kidney failure in patients with diabetes ahead of schedule because it was clear from an interim analysis that the treatment would succeed.
Reuters Health Information
Novo Nordisk will stop a trial studying Ozempic to treat kidney failure in patients with diabetes ahead of schedule because it was clear from an interim analysis that the treatment would succeed.
Reuters Health Information